Despite the ongoing war, Ukraine reaffirms its commitment to evidence- and rights-based drug policy, expanding harm reduction, access to essential medicines and mental health support under its new Strategy to 2030.
This collection examines Europe’s harm reduction journey, including early successes, uneven implementation, securitisation, stigma and medicalisation; and proposes a reframed, people-led approach centring wellbeing, acknowledging drug-use benefits, and advancing rights-based reforms.
IDPC calls on the European Commission to ensure the next Strategy is balanced, evidence-based, and rights-centred, prioritising harm reduction, civil society participation, and policy innovation over punitive approaches.
EHRA, Union for Equity and Health, and PULS urge the Committee to interrogate Moldova’s punitive drug policies, which criminalise people who use drugs, restrict health and employment outcomes, and deepen stigma.
The CSFD calls for an EU Drugs Strategy that puts health, human rights and equity at its core — moving from political statements to real action, with civil society as a full partner.
C-EHRN urges the European Commission to reconsider its decision to eliminate EU4Health operating grants, warning that it endangers vital public health and human rights protections.
Voted by both houses of the Czech parliament, the bill would decriminalise cannabis home cultivation (up to 3 plants) and possession (up to 100g in private), and enable medical access to psilocybin.
124 NGOs from 48 countries condemn Hungary’s 2025 drug war crackdown on people who use drugs, harm reduction services, and civil society, calling for urgent Europe-wide action.
As the EU prepares its 2026–2030 Drug Strategy, we call for a balanced, health-oriented approach that prioritises harm reduction and rights protections instead of punishment.
